Results 11 to 20 of about 349,304 (383)

Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia [PDF]

Haematologica, 2018
Dasatinib, a second-generation BCR-ABL1 tyrosine kinase inhibitor, is approved for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia, both as first-line therapy and after imatinib intolerance or ...
T. Hughes, P. Laneuville, P. Rousselot, D. Snyder, D. Réa, N. Shah, D. Paár, E. Abruzzese, A. Hochhaus, J. Lipton, J. Cortes   +10 more
semanticscholar   +4 more sources

Diagnostic value of procalcitonin in pleural effusion

Egyptian Journal of Chest Disease and Tuberculosis, 2020
Background A wide range of diseases can cause pleural effusion. Its diagnosis and management remain a clinical challenge, bearing a significant cost to both patients and health care system.
Abdelsadek H Al-Aarag, Shuzan A Mohammed, Hoda Y Ibrahim, Osama I Mohammad   +3 more
doaj   +1 more source

Splenic Haematoma as A Rare Cause of Pleural Effusion: A Case Report [PDF]

Journal of Clinical and Diagnostic Research, 2021
Pleural effusion has various aetiologies, mostly located either in the lung parenchyma or in the pleura. Subphrenic causes, leading to exudative pleural effusion are uncommon.
Kashish Dutta, Anuj Kumar, Surabhi Jaggi, Mandeep Kaur Sodhi, Deepak Aggarwal   +4 more
doaj   +1 more source

The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion

European Respiratory Journal, 2020
Introduction Pathophysiology changes associated with pleural effusion, its drainage and factors governing symptom response are poorly understood. Our objective was to determine: 1) the effect of pleural effusion (and its drainage) on cardiorespiratory ...
S. Muruganandan, M. Azzopardi, Rajesh Thomas, D. Fitzgerald, Y. Kuok, H. M. Cheah, C. Read, C. Budgeon, P. Eastwood, S. Jenkins, Bhajan Singh, K. Murray, Y. Lee   +12 more
semanticscholar   +1 more source

Use of a hybrid intelligence decision tree to identify mature B‐cell neoplasms

Cytometry Part B: Clinical Cytometry, EarlyView., 2023
Abstract Background Mature B‐cell neoplasms are challenging to diagnose due to their heterogeneity and overlapping clinical and biological features. In this study, we present a new workflow strategy that leverages a large amount of flow cytometry data and an artificial intelligence approach to classify these neoplasms. Methods By combining mathematical
Inès Vergnolle, Theo Ceccomarini, Alban Canali, Jean‐Baptiste Rieu, François Vergez   +4 more
wiley   +1 more source

Dynamic and volumetric variables reliably predict fluid responsiveness in a porcine model with pleural effusion [PDF]

, 2013
Background: The ability of stroke volume variation (SVV), pulse pressure variation (PPV) and global end-diastolic volume (GEDV) for prediction of fluid responsiveness in presence of pleural effusion is unknown.
A Kumar, A Peris, A Rhodes, Berthold Bein, Cordula M. Stover, D De Backer, D De Backer, D Osman, D Talmor, D Talmor, DA Reuter, E Azoulay, EE de Waal, F Michard, F Michard, G Dechman, J Graf, J Mayer, J Renner, J Renner, J Sagrista-Sauleda, Jan Schöttler, Jochen Renner, K Vaska, Katharina Heß, M Balik, M Cannesson, M Cannesson, M Hadian, Markus Steinfath, Matthias Gruenewald, MR Lopes, MR Pinsky, O Broch, O Nishida, Ole Broch, P Pelosi, Patrick Meybohm, PE Marik, R Jacob, R Pearse, RJ Trof, S Heenen, S Magder, S Rex, S Rex, SG Sakka, SH Loring   +47 more
core   +8 more sources

Malignant Pleural Effusion: Diagnosis and Management

Canadian Respiratory Journal, 2020
Symptomatic malignant pleural effusion is a common clinical problem. This condition is associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies are contributing evidence on an increasing number of therapeutic options
L. Ferreiro, J. Suárez-Antelo, J. Álvarez-Dobaño, M. Toubes, V. Riveiro, L. Valdés   +5 more
semanticscholar   +1 more source

Role of CRP as a marker for discrimination of exudative and transudative pleural effusion

Monaldi Archives for Chest Disease, 2022
Differentiation between exudative and transudative pleural effusion is sometime problematic. This study aimed to evaluate the diagnostic value of C-reactive protein (CRP) in differentiation of exudative and transudative pleural effusion.
Omid Rismantab, Seyed Aili Javad Moosavi, Mohammad Reza Farahnak, Maryam Dastoorpoor, Hanieh Raji   +4 more
doaj   +1 more source

A refractory pleural effusion caused by a pleural capillary hemangioma

Respiratory Medicine Case Reports, 2021
A 69-year-old man presented with a left pleural effusion. Even after repeated drainage, the pleural effusion had been increasing for more than two years.
Kazumasa Akagi, Toyoshi Matsutake, Kiyoyasu Fukushima, Hiroshi Mukae, Hirokazu Kurohama, Hirofumi Matsumoto   +5 more
doaj   +1 more source

Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis

Clinical Research in Cardiology, 2020
Pericardial and pleural effusion are common findings in patients with cardiac amyloidosis (CA). It is not known, whether effusions correlate with right ventricular (RV) function in these patients.
Christina Binder, F. Duca, T. Binder, R. Rettl, T. Dachs, B. Seirer, L. Camuz Ligios, F. Dusik, C. Capelle, H. Qin, H. Agis, R. Kain, C. Hengstenberg, R. Badr Eslam, D. Bonderman   +14 more
semanticscholar   +1 more source